NasdaqCM - Nasdaq Real Time Price USD
Alzamend Neuro, Inc. (ALZN)
0.6851
-0.0049
(-0.71%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Operating Cash Flow
-7,306.1880
-8,269.9930
-8,923.1520
-6,613.9900
-2,712.0270
Investing Cash Flow
-90
-147.2430
--
-106.4580
100.9150
Financing Cash Flow
10,471.4560
3,652.4250
0.2000
18,854.9890
4,450.0970
End Cash Position
3,358.1350
376.0480
5,140.8590
14,063.8110
1,929.2700
Capital Expenditure
-90
-147.2430
--
-106.4580
--
Issuance of Capital Stock
10,171.4560
3,352.4250
--
18,911.4560
2,100
Issuance of Debt
--
300
--
--
402.1100
Repayment of Debt
--
--
--
-58.6670
-1.9180
Free Cash Flow
-7,396.1880
-8,417.2360
-8,923.1520
-6,720.4480
-2,712.0270
4/30/2021 - 6/15/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACOG Alpha Cognition Inc. Common Stock
4.9200
+7.89%
RLYB Rallybio Corporation
0.2956
+4.08%
GLMD Galmed Pharmaceuticals Ltd.
1.6300
+10.88%
BCDA BioCardia, Inc.
1.8580
+4.38%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.2810
-7.26%
PYPD PolyPid Ltd.
2.7500
+0.36%
ARMP Armata Pharmaceuticals, Inc.
1.3200
+1.08%
ERNA Ernexa Therapeutics Inc.
0.1938
+5.21%
GTBP GT Biopharma, Inc.
2.2300
+2.29%
ZVSA ZyVersa Therapeutics, Inc.
0.7080
+6.47%